All autopsies

// STARTUP COMPARISON

Nexura vs Medicinas Online

Nexura failed in 2020 due to Bad Timing. Medicinas Online failed in 2020 due to Regulation. Different causes, different sectors, different eras — but the same simulation outcome.

METRIC🔥 Nexura🔥 Medicinas Online
SectorHealthtechHealthtech
CountryColombiaMexico
Founded20172015
Died20202020
Raised$2M$15M
Peak50 clinic partners$15M raised
Primary CauseBad TimingRegulation

// WHY EACH FAILED

🔥 Nexura
Bad Timing
Nexura built a telemedicine platform connecting Colombian patients with specialist doctors. It had 50 clinic partnerships when COVID-19 hit in March 2020. The pandemic initially seemed like a tailwind — telemedicine demand exploded. But well-funded competitors including Doctoralia, Doctoranytime, and hospital-backed platforms entered the market simultaneously with COVID-era capital. Nexura could not compete for physician supply or patient acquisition against better-capitalized entrants.
// LESSON
A pandemic tailwind attracts well-funded competition as fast as it creates demand. If you're the underfunded incumbent when the tailwind hits, you get flooded, not lifted. Raise ahead of the macro event, not during it.
🔥 Medicinas Online
Regulation
Medicinas Online built one of Mexico's first digital pharmacy platforms, allowing patients to order medications for home delivery. COFEPRIS (Mexico's FDA equivalent) tightened digital pharmacy regulations, requiring original physical prescriptions for controlled substances and antibiotics. The regulatory friction at the point of dispensing — requiring patients to present physical documents — eliminated the core convenience proposition and made the business model significantly harder to scale. The company shut down in 2020.
// LESSON
Digital pharmacy in Mexico requires solving the prescription authentication problem before scaling. COFEPRIS's physical prescription requirement is not a temporary regulatory state — it is the intended regulatory design. Build the compliance layer first.

// EXPLORE FURTHER